This article was originally published in The Tan Sheet
Natural Products marketer records sales of $3.0 mil. for the company's fiscal 2004 third quarter ended Dec. 31, an 22% increase over the prior-year period's sales, Cyanotech announced early this month. Gross profit margin for the third quarter was 39%, a 10% increase compared to third quarter of 2002, resulting from heightened bulk sales of the natural astaxanthin products NatuRose and BioAstin. Though sales of Spirulina Pacifica remained relatively flat, the company succeeded in increasing production of the microalgae...
You may also be interested in...
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.
Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals.
Unfounded expectation some firms have for FDA to protect their investments in preparing successful NDI notifications is part of industry’s overall interest in increased regulation of the market, says Steven Tave, Office of Dietary Supplement Programs director.